NCT01520389 Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment Status COMPLETED Phase PHASE1
NCT01512758 A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT01497626 Lapatinib and Bortezomib in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT01494688 A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01491204 Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer Status COMPLETED Phase PHASE1
NCT01482156 Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01472003 An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types Status COMPLETED Phase PHASE1
NCT01469052 First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01433991 A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2) Status TERMINATED Phase PHASE1/PHASE2
NCT01421004 Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01413893 An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01406119 An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01386866 Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Status COMPLETED Phase PHASE1
NCT01363232 Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients Status COMPLETED Phase PHASE1
NCT01352273 MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations Status COMPLETED Phase PHASE1